CITY COLLEGE OF NEW YORK
Developing an FDA-Qualified Clinical Outcomes Assessment for Opioid Withdrawal
Developing an FDA-Qualified Clinical Outcomes Assessment for Opioid Withdrawal is a funding opportunity from CITY COLLEGE OF NEW YORK, up to 775439, closing May 31, 2027.
May 31, 2027
(304d left)Overview
This proposal responds to RFA-DA-25-028 to develop and validate a Clinical Outcome Assessment (COA) for opioid withdrawal, in line with FDA guidelines for qualification. Given the profound variability observed in the assessment of opioid withdrawal as well as limited psychometric support of existing scales, there is a…